the-infoshop.com - The vertical markets research portal
View CartView Cart
Global Information, Inc.
US: +1-860-674-8796
EU: +32-2-535-7543
SG: +65-6223-2436
  Home | Catalog | E-mail Alert | Custom Research | About The Infoshop | Contact Us | Site Map |

* View All Categories
Japanese Korean Chinese

[Report]

Cigarettes and Smoking Cessation Aids - US - March 2008

Published: 2008/03

Contact 24 hrs/day
Description

Table of Contents

  • Scope and Themes
  • What you need to know
  • Definition
  • Data sources
  • Sales data
  • Consumer survey data
  • Abbreviations and terms
  • Abbreviations
  • Terms
  • Executive Summary
  • Cigarette market remains strong, despite legislation, social mores
  • Cessation market tiny relative to cigarette market
  • Retailing separately not beneficial to NRT sales
  • Convenience stores main retail location, followed by tobacco stores
  • Hard to compete with big tobacco companies
  • GlaxoSmithKline dominates smoking cessation market
  • Product innovation directly addresses increased difficulty of lighting up
  • Market Size and Forecast--Tobacco Products
  • Key points
  • Smoking rates stabilize
  • Cost drives the market for cigarettes down
  • Smoking fewer cigarettes means less sales
  • Smoking habits follow trends set by legislation
  • Strong potential for growth in NRTs, smokeless tobacco
    • Figure 1: Total U.S. sales and forecast of cigarettes and tobacco products, at current prices, 2003-10
    • Figure 2: Total U.S. sales and forecast of cigarettes and tobacco products, at constant prices, 2003-10
  • Market Size and Forecast--Cessation Products
  • Key points
  • Are NRTs effective as a cessation aid?
  • Continued increase in cigarette prices should benefit cessation aids
  • Chronic use benefits market
    • Figure 3: U.S. FDMx sales and forecast of smoking cessation products, at current prices, 2003-11
    • Figure 4: U.S. FDMx sales and forecast of smoking cessation products, at current prices and constant prices, 2003-11
  • Competitive Context
  • Smokeless cigarettes and nicotine delivery systems
  • Zyban (buproprion/Wellbutrin)
    • Figure 5: Brand of smoking cessation aid used, 2003 and 2007
  • Non-product-based methods of quitting smoking
  • Segment Performance--Overview
  • Key points
  • Tobacco segment performance
  • New products and private label cannibalize sales, rather than adding to them
  • Smokers have an oral fixation, as it turns out
    • Figure 6: FDMx sales of cessation products, by segment, 2003-07
    • Figure 7: FDMx sales of cessation product, by segment, 2005 and 2007
  • Retail Channels
  • Key points
  • Promotion affects retail distribution of cigarettes
  • Consumers perceive smoking cessation aids as a pharmaceutical
  • Competition from Internet, black market sales
    • Figure 8: Cigarette sales, by retail channel, 2003 and 2007
  • Retail Channels--C-stores
  • Key points
  • Convenience and price make c-stores/gas stations the leading distribution outlet
  • Price
    • Figure 9: Convenience store sales of cigarettes and tobacco products, at current prices, 2003-07
    • Figure 10: Convenience store sales of cigarettes and tobacco products, at constant prices, 2003-07
  • Retail Channels--Tobacco Stores
  • Key points
  • Quality and selection important to today' s smoker
  • Internet necessary for tobacco store success
    • Figure 11: Tobacco store sales of cigarettes and tobacco products, at current prices, 2003-07
    • Figure 12: Tobacco store sales of cigarettes and tobacco products, at constant prices, 2003-07
  • Market Drivers
  • Health-concerned city and state policies make smoking difficult
    • Figure 13: Attitudes towards smoking legislation, January 2008
  • Corporate wellness programs
  • Reward and punishment
  • Leading Companies
  • Key points
  • Philip Morris carries over half the market
    • Figure 14: FDMx sales of leading tobacco and anti-smoking companies, 2006 and 2007
  • Brand Share--Cigarettes and Other Tobacco Products
  • Key points
  • If I' m going to do it, I might as well do it up
  • New lines, new campaigns bolster Camel sales
  • Newport aided by popularity in urban market
  • Brand awareness stronger than manufacturer awareness
    • Figure 15: FDMx brand sales of cigarettes and tobacco products in the U.S., 2006 and 2007
  • Lighter smokers spend more per pack
    • Figure 16: Branded or private label cigarette smoked, by daily cigarette consumption, May 2006-June 2007
  • Brand Share--Smoking Cessation Products
  • Key points
  • Private label continues to gain ground
    • Figure 17: FDMx brand sales of nicotine replacement treatments, 2006 and 2007
  • Brand Qualities--Changes for Camel, Marlboro, Kool
  • Overview
  • Camel chases women
  • Marlboro Smooth takes aim at Newport and Kool
  • Kool XL targets younger smokers
  • Waiting for the black market to sour
  • Innovation and Innovators
  • Key points
  • Marlboro offers up a quicker fix
  • Invasion of the potentially reduced-exposure products
  • Smokeless Snus
  • Advertising and Promotion
  • Regulated environment favors discounts and sponsorships
  • Online promotions limited to consumers with substantial initiative
    • Figure 18: Ad spending by tobacco and anti-smoking brands, 2005 and 2006
  • Marlboro continues to forego traditional avenues of promotion
  • Camel backs down from print ads
  • GlaxoSmithKline
  • NicoDerm
    • Figure 19: TV ad for GlaxoSmithKline' s NicoDerm CQ nicotine patch, 2008
  • Nicorette
    • Figure 20: TV ad for GlaxoSmithKline' s Nicorette Anti-smoking gum, 2007
  • Commit
    • Figure 21: TV ad for GlaxoSmithKline' s Commit anti-smoking lozenges, cherry flavor, 2007
    • Figure 22: TV ad for GlaxoSmithKline' s Commit anti-smoking lozenges, mint flavor, 2007
    • Figure 23: TV ad for GlaxoSmithKline' s Commit anti-smoking lozenges, 2007
  • Smoking Habits and History
  • Two thirds of current regular smokers have tried to quit
    • Figure 24: Smoker status, by age, January 2008
  • Incidence of smoking
    • Figure 25: Cigarette smoking, 2001 and 2007
    • Figure 26: Usage of cigarettes, by age, May 2006-June 2007
  • Efforts to Quit Smoking
  • Usage of nicotine replacement therapy products
    • Figure 27: Use of anti-smoking products in the previous year, 2001 and 2007
  • Vast majority of current smokers have tried to quit multiple times
    • Figure 28: Number of quit smoking attempts, by smoker status, January 2008
  • Products Used in Efforts to Quit Smoking
  • "Cold turkey" remains the most popular quitting method
    • Figure 29: Type of anti-smoking product tried in last 12 months, by daily cigarette consumption, May 2006-June 2007
  • Cessation methods compared between all attempts and successful attempts
    • Figure 30: Ways of trying to quit smoking, by attempt, January 2008
  • Private label drives increased usage of nicotine gum
    • Figure 31: Method tried to quit smoking in previous year, 2001 and 2007
  • Frequency of Cigarette Usage
    • Figure 32: Number of cigarettes smoked per day, 2001 and 2007
  • Men who smoke average two more cigarettes per day than women
    • Figure 33: Number of cigarettes smoked daily, by gender, May 2006-June 2007
  • Older smokers and whites should be targeted for cessation products
    • Figure 34: Number of cigarettes smoked daily, by age, May 2006-June 2007
    • Figure 35: Number of cigarettes smoked daily, by race/ethnicity, May 2006-June 2007
  • Targeting spouses and the gift market for cessation aids
    • Figure 36: Number of cigarettes smoked daily, by marital status, May 2006-June 2007
  • Race and Ethnicity
    • Figure 37: Smoking, by race/ethnicity, 2003 and 2007
    • Figure 38: Attitudes towards smoking-related illness, by race/ethnicity, January 2008
  • Menthol use rising due to the increased importance of black smokers
    • Figure 39: Type of cigarette smoked, 2003 and 2007
  • Attitudes and Motivations Regarding Smoking
  • Introduction
  • Compromise solutions and addiction as an illness
    • Figure 40: Smoking/quitting, compromise solutions, and opinions on addiction as an illness, January 2008
  • More than one in three current smokers have never considered long-term health impacts
    • Figure 41: Expected outcome of smoking habit, January 2008
  • You get what you pay for
    • Figure 42: Existence of favorite brand and interest in quality, January 2008
  • Striking interest in better-for-you product
    • Figure 43: Attitudes towards making choices of what to smoke, January 2008
    • Figure 44: Attitudes towards quitting smoking, January 2008
  • Why the majority of current smokers will not try NRTs
    • Figure 45: Attitudes towards cessation aids, January 2008
  • Reasons for Smoking
  • Smokers start young
  • Calming the nerves
  • Nicotine addiction may be a symptom of a larger psychiatric problem
  • Smoking may be a symptom of a larger health problem
    • Figure 46: Usage of cigarettes, by ailment, January 2008
    • Figure 47: General attitudes and behaviors around smoking, January 2008
  • Appendix: Trade Associations
Description

[Report]
Cigarettes and Smoking Cessation Aids - US - March 2008
Published: 2008/03
Published by : Mintel International Group Ltd, Mintel International Group Ltd,

Price:
US $ 3,995.00 Hard Copy
US $ 3,995.00 PDF by E-mail (Site License)
US $ 5,495.00 PDF by E-mail (2 Site License)
>
Product Code : MT64503
Please inform me when related publications are released
InfoWatch

Available 24 Hours a Day
US: 1-860-674-8796 EU: 32-2-535-7543 SG: 65-6223-2436
The vertical markets research portal
© 2008, the-infoshop.com by Global Information, Inc. All rights reserved.